Hamid Khoja insider trades
Open-market stock purchases and sales by Hamid Khoja, Chief Scientific Officer at FibroBiologics, Inc, from SEC Form 4 filings since Aug 12, 2024.
Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +49%.
Companies traded
- FBLG FibroBiologics, Inc: 3 buys, last May 4, 2026